Malignant peritoneal mesothelioma (MPM) is a rare and aggressive cancer associated with a poor prognosis. Its presentation mimics a spectrum of conditions, making diagnosis and management particularly ...

January 6, 2011 — Cases of malignant mesothelioma, caused almost exclusively by exposure to asbestos, are significantly underreported worldwide, concludes a new study published online January 6 in ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to chemotherapy significantly extended OS as first-line therapy for advanced ...

Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer ...

Future Oncol. 2009;5(3):391-402. 1 Laboratory of Molecular Oncology, Clinic and Policlinic of Oncology, University Hosptial, CH-8091 Zürich, Switzerland. 2 Division of Thoracic Surgery, University ...

In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, ...

Please provide your email address to receive an email when new articles are posted on . PFS defined as the time from randomization to any progression or death served as the primary outcome. Secondary ...

In spring of this year, the Centers for Disease Control and Prevention (CDC) reported a 20-year rise in the number of mesothelioma deaths in women. Analyzing annual Multiple Cause of Death records ...

Nearly one in five patients with malignant pleural mesothelioma (MPM) at a Barcelona hospital contracted COVID-19 during the pandemic. In addition, those patients suffered a 75% mortality rate, ...

A ‘PROUD and devoted’ family man has died from immunotherapy related toxicities in hospital, an inquest heard.